Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder

Clinical trial NCT00788034 · COMPLETED

Trial details

NCT number: NCT00788034
Sponsor: H. Lundbeck A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2008-10-01
Primary completion: 2010-06-01
Enrollment: 459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.